Pictet Asset Management (Switzerland)’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $26.9M | Buy |
582,976
+248,943
| +75% | +$11.5M | 0.03% | 397 |
|
|
2023
Q1 | $13.4M | Buy |
334,033
+253,463
| +315% | +$10.2M | 0.02% | 550 |
|
|
2022
Q4 | $3.73M | Buy |
80,570
+22,075
| +38% | +$1.02M | 0.01% | 799 |
|
|
2022
Q3 | $2.42M | Buy |
58,495
+54,095
| +1,229% | +$2.24M | ﹤0.01% | 887 |
|
|
2022
Q2 | $263K | Hold |
4,400
| – | – | ﹤0.01% | 1321 |
|
|
2022
Q1 | $320K | Hold |
4,400
| – | – | ﹤0.01% | 1325 |
|
|
2021
Q4 | $370K | Hold |
4,400
| – | – | ﹤0.01% | 1295 |
|
|
2021
Q3 | $397K | Buy |
+4,400
| New | +$397K | ﹤0.01% | 1287 |
|